Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 study evaluating rosuvastatin in children and adolescents with homozygous familial hypercholesterolemia has completed, and results have been posted. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Homozygous Familial Hypercholesterolemia (HoFH) | Phase 3 | Status: COMPLETED | Results posted: 2016-07-04